Novel yet simple model provides smooth answer to friction mystery
Peer-Reviewed Publication
Updates every hour. Last Updated: 7-Jul-2025 06:11 ET (7-Jul-2025 10:11 GMT/UTC)
Atoms slip against one another, eventually sticking in various combinations. Tectonic plates do the same, sliding across each other until they stick in a stationary state. Everything from the tiniest particles to unfathomably large landmasses possesses this fundamental stick and slip characteristic, but only now are scientists beginning to understand the mechanics of the friction underpinning this property.
Research led by Hiromi Shiraishi, researcher at Chuo University, has revealed that, in addition to Japanese Eel (Anguilla japonica), American Eel (Anguilla rostrata) is now widely distributed in processed eel products sold at retail stores across Japan. While eel farming in Japan relies primarily on Japanese Eel, two-thirds of eel consumption in the country depends on imports of live adult eels and eel products, which include several species of anguillid eels. As the world’s largest importer and consumer of eel, Japan is in a position to contribute to the sustainable use of anguillids beyond Japanese eel.
- Development of "dynamic nanomedicines" for efficient delivery of nucleic acid medicines to sentinel lymph nodes.
- Delivering nucleic acid medicines to sentinel lymph nodes, which serve as a checkpoint for cancer metastasis, activates the immune system, helping to suppress cancer metastasis and recurrence.
- Enhancing cancer immunotherapy to make it effective against immunotherapy-resistant tumors.
- Precise size adjustment of nanomedicines (approximately 10 nm) enables delivery to sentinel lymph nodes.
- Precision nanomedicine design via advanced computational modelling.
- Aim to start clinical trials within five years.
- This announcement is part of a research project conducted by Professor Kanjiro Miyata of the Graduate School of Engineering, The University of Tokyo (Visiting Research Scientist at iCONM), in collaboration with iCONM researchers.
An Osaka Metropolitan University research team assessed whether the use of 5-aminosalicylic acid during vedolizumab treatment helps prevent relapse in ulcerative colitis and Crohn’s disease.